HMC+ writes a chapter for chitosan anthology
Experts and researchers from academia, industry and regulatory bodies provide a concise and up-to-date overview about the mentioned topic. The anthology has four parts:
1. General aspects of chitosan and its derivatives
2. Chitosan and its derivatives in connection with
formulation and delivery of biopharmaceuticals
3. Specific applications in the filed of biopharmaceuticals
4. Regulatory, manufacturing and toxicological
requirements.
The aim of the editors was to create a well-grounded benchmark with clearly prepared basic information.
HMC+ also was requested to write an article in this anthology. The author selection was made by the editors first of all. Afterwards they sent an invitation for writing an article. An invitation that HMC+ gladly accepted.
The chapter of HMC+ with the headline: “Quality Control and Good Manufacturing Practice (GMP) for Chitosan-Based Biopharmaceutical Products” is in the fourth part of the book. Torsten Richter, Maika Gulich and Katja Richter refer about:
- Regulatory requirements for production
- Fundamental considerations of GMP manufacturing
- Requirements for rooms, personnel and equipment
- Qualification and validation
- Quality control
- Monitoring and maintenance of a GMP system and
- Future perspectives.
Overall the book has 584 pages and is available as hardcover or e-book. You can find a detailed table of contents on the product page of the publisher Wiley. There you can also buy the anthology.
Die ISBN is: 978-0-470-97832-0.
Have fun reading the book. Your HMC+-Team
If you have further questions do not hesitate to contact us by phone or by mail.
Further links:
Regard the Google preview.
Visit the Wiley website to forage for more articles.
Source of the picture: Wiley